Biotricity is trading at $0.11, down 8.42%, after no new company-specific catalyst was identified for August 28, 2026.
- Volume is 13.59K, below the 87.34K average.
- Broader indexes are modestly positive, offering no clear market-wide explanation.
- The latest identifiable filing was the August 19, 2026 Form 10-Q, not a fresh catalyst.